USD 45M Series B Funding for UK-Based Biopharmaceutical Company’s Drug Discovery Programmes
The pathways that control the behaviour of cells are complex, non-linear and highly redundant. As such, identifying the right molecular target for the development of next-generation drugs is oftentimes akin …